Lv3
210 积分 2025-05-08 加入
Neoadjuvant Therapy Versus Upfront Surgery for Patients With Clinical Stage 2 or 3 Esophageal Squamous Cell Carcinoma: A Cost-Effectiveness Analysis
6天前
已完结
Neoadjuvant treatment strategies for HER2-positive breast cancer: cost-effectiveness and quality of life outcomes
6天前
已完结
Cost-effectiveness analysis of neoadjuvant immune checkpoint inhibition vs. cisplatin-based chemotherapy in muscle invasive bladder cancer
6天前
已完结
Neoadjuvant Treatment Versus Upfront Surgery in Resectable Pancreatic Cancer: A Cost-Effectiveness Analysis
6天前
已完结
Cost-Utility of "Doxorubicin and Cyclophosphamide" versus "Gemcitabine and Paclitaxel" for Treatment of Patients with Breast Cancer in Iran
6天前
已关闭
Mapping the Beck Depression Inventory to the EQ-5D-3L in Patients with Depressive Disorders
13天前
已完结
Mapping the Chinese Version of the EORTC QLQ-BR53 Onto the EQ-5D-5L and SF-6D Utility Scores
21天前
已完结
Development of algorithms to estimate the EQ-5D-5L from the FACT-L in patients with lung cancer: a mapping study
1个月前
已完结
Deriving Health Utility Values Using Mapping Methods Among the Chinese Population: A Systematic Review
1个月前
已完结
Cost-effectiveness analysis of ribociclib plus fulvestrant for hormone receptor-positive/human EGF receptor 2-negative breast cancer
3个月前
已完结
皖公网安备34019202002308
